Optio attends CHDI – February 2020, Palm Springs, USA

Optio attends the 2020 CHDI conference in Palm Springs. CHDI is the premier scientific conference advancing therapeutic options for Huntington’s disease (HD). Optio Biopharma Solutions is a leading rare disease pharmaceutical commercial services agency committed to staying current on scientific and clinical developments in HD.



Leave a Reply